2021
DOI: 10.4110/in.2021.21.e35
|View full text |Cite
|
Sign up to set email alerts
|

IL-17 and IL-17C Signaling Protects the Intestinal Epithelium against Diisopropyl Fluorophosphate Exposure in an Acute Model of Gulf War Veterans' Illnesses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 50 publications
0
4
0
Order By: Relevance
“…They concluded that DFP-exposed mice significantly reduced tight junction proteins (claudin-4 and occludin) and their corresponding mRNA expression in the large intestine. This study also found that the loss of IL-17, a pro-inflammatory cytokine with protective properties in the intestinal epithelium, can exacerbate tight junction reduction in an acute model of GWI [17]. Moreover, exposure to DFP has led to a significant decrease in the antimicrobial peptide (AMP) secreted by intestinal epithelial cells.…”
Section: Gut Dysbiosismentioning
confidence: 62%
See 3 more Smart Citations
“…They concluded that DFP-exposed mice significantly reduced tight junction proteins (claudin-4 and occludin) and their corresponding mRNA expression in the large intestine. This study also found that the loss of IL-17, a pro-inflammatory cytokine with protective properties in the intestinal epithelium, can exacerbate tight junction reduction in an acute model of GWI [17]. Moreover, exposure to DFP has led to a significant decrease in the antimicrobial peptide (AMP) secreted by intestinal epithelial cells.…”
Section: Gut Dysbiosismentioning
confidence: 62%
“…Moreover, exposure to DFP has led to a significant decrease in the antimicrobial peptide (AMP) secreted by intestinal epithelial cells. The loss of AMP compromises the intestinal microbiome and may underlie to dysbiosis [17]. Collectively, these works implicate that gut decontamination of GWI patients coupled with restoring a healthy gut microbiome and introducing essential bacterial metabolites such as butyrate and intestinal cytokines such as IL-17 may attenuate certain symptoms with the caveat that additional research is a requirement before clinical testing can be justified.…”
Section: Gut Dysbiosismentioning
confidence: 95%
See 2 more Smart Citations